InvestorsHub Logo

BiotechValues

05/21/09 9:10 PM

#610 RE: goby112 #609

I haven't looked at the filing in detail yet to comment- been busy. Will look tomorrow and post on it. A quick glance says they're strong in revenues but spending too much in managemet fees, salaries, etc. Need more time to study it. Considering how bad Q4 was that brought down eps for the year to only .05, this report looks like an improvement on the surface.